Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 952-967-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Sodium titanates are effectively the sodium salts of the unstable titanic acid (titanium hydroxide). Titanium hydroxide is hard to isolate without rapid hydrolysis to titanium dioxide and sodium chloride. It is therefore proposed to base environmental and health assessment on these two hydrolysis products. There has been extensive research on similar substances in the ‘titanate’ grouping and these all exhibit similar behaviour in that under acid biological conditions (eg if ingested) or if dispersed in water, there is dissociation of the ions and subsequent hydrolysis / oxidation. Read-across justification for the use of TiO2 data is available in section 13.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- Mammalian Erythrocyte Micronucleus Test (1997).
- Principles of method if other than guideline:
- Six pigment-grade (pg) or ultrafi ne (uf)/nanoscale (anatase and/or rutile) titanium dioxide (TiO 2 ) particulates were evaluated for in vivo genotoxicity (OECD 474 Guidelines) in male and female rats by two different laboratories. All test materials were robustly characterized. The BET surface areas of the pg and uf samples ranged from 7 to 17 m 2 /g and 50 to 82 m 2 /g respectively. The materials were assessed for induction of micronuclei and toxicity in bone marrow by analyzing peripheral blood reticulocytes (RETs) byfl ow cytometry. Single oral gavage doses of 500, 1000 or 2000 mg/kg body weight (bw) of each material were implemented with concurrent negative (water) and positive controls (cyclophosphamide).
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Titanium dioxide
- EC Number:
- 236-675-5
- EC Name:
- Titanium dioxide
- Cas Number:
- 51745-87-0
- Molecular formula:
- O2Ti
- IUPAC Name:
- Titanium dioxide
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- 3 pigment-grade, and 3 ultrafi ne titanium dioxide (TiO 2 ) forms were used in this study. The series of samples analyzed spanned the range from test particles containing both anatase and rutile crystallites to both ultrafi ne and pigmentary materials composed of primarily rutile or anatase crystallites.
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD) rats and Wistar Crl:WI (Han) rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Crl:CD(SD) rats were obtained from Charles River Breeding Laboratories, Raleigh, North Carolina, USA. Wistar Crl:WI (Han) rats were obtained from Charles River, Sulzfeld, Germany. Animals were housed and maintained in facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International in accordance with the principles described in the Guide to Care and Use of Laboratory Animals . Tap water and pelleted chow (Certifi ed diet from PMI ® Nutrition International, LLC, Harlan or Purina) or Atromin 1324 were available ad libitum throughout the study.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- The test materials, vehicle, and the positive control were administered as single doses by oral gavage, based on the potential and relevant route for human exposure to TiO 2 in food or dietary supplements. This exposure strategy was considered suitable and most appropriate for the purpose of these studies, mimicking the likely human exposure route for any food or dietary supplement application incorporating TiO2 particles. Sterile water was used as the vehicle in all cases
- Details on exposure:
- Based on range-fi nding results, doses of 500, 1000, and 2000 mg/kg body weight (bw) of each test material were selected for the micronucleus tests. Concurrent control groups were administered sterile water, as the vehicle (negative) control, or 10 mg/kg bw of cyclophosphamide (positive control).
- Duration of treatment / exposure:
- On the day of dosing, all study animals were between 7 and 8 weeks of age, with body weights within ± 20% of the mean. Five animals per sex per dose group (seven in the highest dose group) were dosed by oral gavage (dose volume 10 mL/kg bw) as follows: 1) vehicle control (0 mg/kg bw); 2) low dose (500 mg/kg bw); 3) intermediate dose (1000 mg/kg bw); 4) high dose (2000 mg/kg bw); and 5) positive (cyclophosphamide) control (10 mg/kg bw).
- Frequency of treatment:
- Single dose
- Post exposure period:
- Approximately 48 and 72 h after exposure, blood samples were collected and 20,000 RETs per animal were analyzed.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw (total dose)
- Dose / conc.:
- 500 mg/kg bw (total dose)
- Dose / conc.:
- 1 000 mg/kg bw (total dose)
- Dose / conc.:
- 2 000 mg/kg bw (total dose)
- No. of animals per sex per dose:
- Five animals per sex per dose group (seven in the highest dose group)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- positive controls (cyclophosphamide)
Examinations
- Tissues and cell types examined:
- The materials were assessed for induction of micronuclei and toxicity in bone marrow by analyzing peripheral blood reticulocytes (RETs) by flow cytometry.
- Evaluation criteria:
- The objective of these six studies was to evaluate the potential of the test materials, namely 3 pigment-grade, and 3 ultrafi ne titanium dioxide (TiO2 ) forms, to induce micronuclei in rat bone marrow by analyzing micronucleated reticulocytes (MN-RETs) in rat peripheral blood cells. An increase in the frequency of MN-RETs relative to negative controls would indicate that a test material induces chromosomal and/or cell spindle damage in erythroblasts. Possible toxic effects (inhibition of erythropoiesis) may be indicated by a signifi cant decrease in the frequency of reticulocytes (RETs) among the total erythrocytes [RETs plus normochromatic erythrocytes (NCEs)].
- Statistics:
- A test was considered valid if the range of MN-RET values in the vehicle control animals were within reasonable limits of the laboratory historical control range, and if the positive control induced a signifi cant increase in the frequency of MN-RETs as compared to the vehicle control group, judged by biological and/or statistical signifi cance (p 0.05).
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Titanium was present in blood and liver of untreated (control) rats. Tissue concentrations of rats treated with 500, 1000, or 2000 mg TiO2 /kg/bw did not show a dose-dependent increase in titanium content. Single oral intubation resulted in no discernible dose-dependent increases of TiO2 in the blood and liver of treated rats relative to control rats.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of these six studies, uf-1, uf-2, uf-3, pg-1, pg-2, and pg-3 titanium dioxide did not induce biologically relevant increases in micronucleated RETs in rat peripheral blood. Accordingly, all of the test materials were concluded to be essentially negative in the in vivo Mammalian Erythrocyte Micronucleus Test specifi c to oral administration, noting that the result can at least in part be attributed to the lack of achieving exposure of the test substance to the bone marrow even at the OECD 474 limit dose of 2000 mg/kg bw, when dosed by oral administration. With the exception of demonstrated target cell exposure, all other criteria for valid studies were met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.